Disclosure Of Interests In Other Entities [Text Block]

Bastide Le Confort Médical - Filing #2808771

Concept	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	As at 2024-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	2 107 EUR	—	—	—	—	—	—	—	—	739,000 EUR	—	—	—	—
Non-controlling interests	—	—	—	—	—	—	—	953,000 EUR	—	443,000 EUR	—	—	—	—	—	—
Current assets	—	—	—	—	—	—	—	208 922 EUR	—	196 412 EUR	—	—	—	—	—	—
Non-current assets	—	—	—	—	—	—	—	438 145 EUR	—	460 668 EUR	—	—	—	—	—	—
Current liabilities	—	—	—	—	—	—	—	216 206 EUR	—	224 985 EUR	—	—	—	—	—	—
Non-current liabilities	—	—	—	—	—	—	—	350 136 EUR	—	344 004 EUR	—	—	—	—	—	—
Profit (loss)	—	—	1 206 EUR	900,000 EUR	—	900,000 EUR	2 107 EUR	—	—	—	12 047 EUR	12 786 EUR	—	739,000 EUR	12 047 EUR	—
Comprehensive income	0 EUR	0 EUR	1 648 EUR	3 771 EUR	0 EUR	3 771 EUR	2 124 EUR	—	0 EUR	—	12 600 EUR	13 339 EUR	0 EUR	739,000 EUR	12 600 EUR	0 EUR
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	4.1.2. Participations dans des entreprises associées et des coentreprises	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Profit (loss) from continuing operations	—	—	9 487 EUR	—	—	—	—	—	—	—	—	16 805 EUR	—	—	—	—
Profit (loss) from discontinued operations	—	—	8 281 EUR	—	—	—	—	—	—	—	—	4 019 EUR	—	—	—	—
Other comprehensive income	—	—	2 854 EUR	2 871 EUR	—	2 871 EUR	17,000 EUR	—	—	—	553,000 EUR	553,000 EUR	—	—	553,000 EUR	—
Investments accounted for using equity method	—	—	—	—	—	—	—	88,000 EUR	—	62,000 EUR	—	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	—	—	—	—	23 616 EUR	—	36 706 EUR	—	—	—	—	—	—
Depreciation and amortisation expense	—	—	63 331 EUR	—	—	—	—	—	—	—	—	58 795 EUR	—	—	—	—
Interest expense	—	—	27 369 EUR	—	—	—	—	—	—	—	—	16 593 EUR	—	—	—	—
Tax expense (income)	—	—	7 015 EUR	—	—	—	—	—	—	—	—	5 960 EUR	—	—	—	—